Literature DB >> 6309703

Results of a survey on radioactivity of building materials in Italy.

G Sciocchetti, G F Clemente, G Ingrao, F Scacco.   

Abstract

A program is underway in Italy to identify construction materials with high radioactivity contents and to evaluate the resulting indoor exposure on a nationwide scale. Building materials surveyed include those of natural origin and those employing particular by-products such as fly ash and phosphogypsum. The survey currently emphasizes natural building materials, which are widely used in many areas having particular geological features. First results show that Italy includes areas of high natural background, i.e. in Lazio and Campania, in which very high levels of indoor exposure occur that can be directly related to specific activities of the building materials. Moreover, 220Rn daughters are sometimes present at such levels that their contribution to the lung exposure is comparable to that from 222Rn daughters.

Mesh:

Substances:

Year:  1983        PMID: 6309703     DOI: 10.1097/00004032-198308000-00011

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  3 in total

1.  Adult myeloid leukaemia, geology, and domestic exposure to radon and gamma radiation: a case control study in central Italy.

Authors:  F Forastiere; A Sperati; G Cherubini; M Miceli; A Biggeri; O Axelson
Journal:  Occup Environ Med       Date:  1998-02       Impact factor: 4.402

2.  Exposure to indoor background radiation and urinary concentrations of 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage.

Authors:  A Sperati; D D Abeni; C Tagesson; F Forastiere; M Miceli; O Axelson
Journal:  Environ Health Perspect       Date:  1999-03       Impact factor: 9.031

3.  Assessment of Natural Radioactivity in Cements Used as Building Materials in Poland.

Authors:  Sylwia Lewicka; Barbara Piotrowska; Aneta Łukaszek-Chmielewska; Tomasz Drzymała
Journal:  Int J Environ Res Public Health       Date:  2022-09-16       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.